Paul Maier
Director/Board Member at ETON PHARMACEUTICALS, INC.
Net worth: 267 193 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel O'Connor | M | 59 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 2 years |
| Kate Hermans | F | 56 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 2 years |
| Katrin Rupalla | M | 56 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 4 years |
| Janet Loesberg | M | 61 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 2 years |
| Tom Myers | M | 71 | 13 years | |
| Sonja Nelson | F | 51 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 3 years |
| George Tziras | M | 43 | 3 years | |
| Duncan Peyton | M | 54 | 10 years | |
| Charles Casamento | M | 78 | 14 years | |
| Russell Kern | M | 38 | 16 years | |
| Jared Kelly | M | - |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 1 years |
| Margaret Dalesandro | M | 77 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 1 years |
| Sean Brynjelsen | M | 52 | 7 years | |
| Xiaowei Chang | M | 41 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 9 years |
| Alexander Stevenson | M | 53 | 10 years | |
| Stephen Glover | M | 60 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 1 years |
| Paul Billings | M | 71 |
Biological Dynamics, Inc.
 Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | 2 years |
| Marie Layzell | F | 46 | 3 years | |
| Axel Gaston Glasmacher | M | 64 | 5 years | |
| James Gruber | M | 52 | 2 years | |
| Norbert Riedel | M | 66 | 7 years | |
| Lyne Fortin | F | 64 | 3 years | |
| Shawn Zhang | M | - | - | |
| Paul W. Maffuid | M | 68 | 10 years | |
| Scott Grossenbach | M | - | 6 years | |
| John Kozarich | M | 74 | 21 years | |
| Alexander Macrae | M | 61 | 5 years | |
| Donald Wright | M | 72 | 17 years | |
| David Krempa | M | 35 | 7 years | |
| Irwin Jacobs | M | 90 |
Biological Dynamics, Inc.
Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | 6 years |
| Larry Arakelyan | M | - |
Biological Dynamics, Inc.
Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | - |
| Jason Aryeh | M | 55 | 18 years | |
| Edgardo Baracchini | M | 64 | 5 years | |
| Michael Wolfe | M | 58 | 3 years | |
| Andrey Semechkin | M | 64 | 16 years | |
| Philip O. Livingston | M | 81 | 10 years | |
| Jenn Adams | F | 55 | 3 years | |
| Andrew Aromando | M | 55 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 1 years |
| Ying Buechler | M | - | 6 years | |
| Joshua Keene | M | - |
Mason School of Business of The College of William & Mary
| - |
| Jenny Maguire | F | - | 3 years | |
| Kathryn Butuceanu | F | - |
Mason School of Business of The College of William & Mary
| - |
| Amber Murray | F | - |
Biological Dynamics, Inc.
Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | - |
| Allison Spivey | F | - |
Mason School of Business of The College of William & Mary
| - |
| Mark Begly | M | - |
Mason School of Business of The College of William & Mary
| - |
| Kathleen Lind | F | - |
Mason School of Business of The College of William & Mary
| - |
| Danka Radosavljevic | M | - | - | |
| Travis Patton | M | - |
Mason School of Business of The College of William & Mary
| - |
| Alison Herring | F | - |
Mason School of Business of The College of William & Mary
| - |
| Ingrid Hoos | F | - | - | |
| Robert Mooney | M | - |
Mason School of Business of The College of William & Mary
| - |
| Imke Mulder | F | - | - | |
| George Gibson | M | 58 |
Mason School of Business of The College of William & Mary
| 19 years |
| Glenn Dourado | M | - | - | |
| David Steel | M | - | 3 years | |
| Jakob Dupont | M | 58 | 3 years | |
| Kevin Guthrie | M | - | - | |
| Audrey Warfield-Graham | F | - | 30 years | |
| Edward T. Tokar | M | 76 |
Mason School of Business of The College of William & Mary
| - |
| Michael Stakias | M | 74 |
Mason School of Business of The College of William & Mary
| - |
| Kip Miller | M | 65 |
Biological Dynamics, Inc.
Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | - |
| H. Watkins | M | 71 |
Mason School of Business of The College of William & Mary
| - |
| Lisa M. Wilson | F | 59 | - | |
| Nina Kumari | M | - | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Vivian Liu | F | 62 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | - |
| Bill Welch | M | 62 | 4 years | |
| Feng Tian | M | - |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 18 years |
| Richard Pascoe | M | 60 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | - |
| Peter C. Wulff | M | 65 | 3 years | |
| Raj Mehra | M | 64 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | - |
| Peter Rands | M | 43 | 5 years | |
| Edward Cox | M | 43 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 5 years |
| Wilson Troutman | M | 69 | 5 years | |
| Steven Martin | M | 63 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 3 years |
| Sophia Garnette | F | 40 | 11 years | |
| Jeffrey D. Janus | M | 68 | 8 years | |
| Kleanthis Xanthopoulos | M | 66 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 8 years |
| Kenneth Buechler | M | 70 | 7 years | |
| Kurt A. May | M | - | - | |
| Jay Tibor Novak | M | 58 | 4 years | |
| Raj Krishnan | M | - |
Biological Dynamics, Inc.
Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | 12 years |
| David Norman Nawrocki | M | 74 |
The Pennsylvania State University
| 10 years |
| Russell Ray | M | 53 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 10 years |
| Bassam Damaj | M | 55 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 3 years |
| Charles P. Slacik | M | 70 | 5 years | |
| Randy Berholtz | M | 63 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 2 years |
| Leonard Oppenheim | M | 77 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 10 years |
| K. Boyer | M | 72 |
The Pennsylvania State University
| 13 years |
| James Mead | M | 77 |
The Pennsylvania State University
| 4 years |
| Carlyle F. Griffin | M | 78 |
The Pennsylvania State University
| 6 years |
| Charles Berkman | M | 55 | 21 years | |
| Harry Stylli | M | 62 | 4 years | |
| Andrew J. Buckland | M | 61 | 6 years | |
| Gregory H. Barnhill | M | 71 | 11 years | |
| Warner R. Broaddus | M | - | 6 years | |
| William A. Pettit | M | - | - | |
| David Eric Robinson | M | - | - | |
| Deirdre Y. Gillespie | M | 67 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 6 years |
| Gregory J. Yurek | M | 77 |
The Pennsylvania State University
| 5 years |
| R. William Bowen | M | 71 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 81 | 81.00% |
| Cayman Islands | 11 | 11.00% |
| United Kingdom | 8 | 8.00% |
| Canada | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul Maier
- Personal Network
